Good MorningStocks moved higher Thursday as easing Treasury yields and reduced expectations for a September rate hike supported risk appetite. The Dow gained about 1.2%, while the S&P 500 rose roughly 1.1%. Investors are now focused on the August jobs report, with Fed futures roughly split on the outlook for a September rate increase.
AI-driven technology remained a major market theme. Snowflake surged about 18% after reporting stronger-than-expected quarterly results, accelerating product revenue growth, and higher guidance supported in part by AI demand. Broadcom delivered an earnings beat and bullish longer-term AI revenue outlook, though its shares fell after fourth-quarter revenue guidance came in below expectations. Dell also drew praise following a blowout quarter.
Retail brokerage stocks rallied, led by Robinhood, which climbed about 16% amid analyst upgrades, optimism around prediction markets, and a rebound in Bitcoin. Tesla gained ahead of its closely watched Cybercab event, while investors also monitored signs of progress in Nike’s turnaround, including improving wholesale trends and margins. In corporate news, BASF sued Apple over alleged infringement of face-authentication patents. Featured: Action To Take: Buy These Five Stocks Before September 30th (Ad) 
|
Technology | |
Broadcom's (NASDAQ: AVGO) latest earnings report was among the most revealing the company has posted recently.
Another quarter of explosive AI sales growth stood out, but the quarter itself was far from the biggest story.
Management also provided key stats and insights that help investors gain a ... Read the Full Story |
|
From Our Partners | | Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the largest markets in the world.
James Altucher, who previously flagged Nvidia in 2008 and Bitcoin in 2013, says the filing could rival Tesla, SpaceX and xAI combined.
Few investors know this filing exists, but that is expected to change quickly. | | Click here to see details on Elon Musk's newest AI filing |
|
Technology | |
Silicon alone does not guarantee a lasting monopoly. For years, the market valued NVIDIA Corporation (NASDAQ: NVDA) largely on the dominance of its data-center hardware. But the hyperscaler wars are evolving. Building the fastest chips is no longer enough when major cloud providers are aggressivel... Read the Full Story |
|
Consumer Discretionary | |
The fast-food industry is facing a severe reality check. Menu price hikes are pricing out the core lower-income demographic, causing a decline in foot traffic across the sector. Yet amid this crisis, one operator just executed a masterclass in corporate defense.
Yum! Brands (NYSE: YUM) successfull... Read the Full Story |
|
From Our Partners | | Ever been right about a stock's direction and still lost money on the trade? It's almost never bad luck - it's a checkpoint you skipped.
The Smart Trade Options Checklist puts the 7 most important pre-trade checks on one page. Normally $29.97, it's free today. Run it in about 30 seconds before any options trade to catch the bad ones before they cost you. | | Download the free 7-point options checklist right here |
|
Consumer Discretionary | |
Technical indicators aren’t crystal balls, but when a death cross emerges on a stock’s chart, it tends to catch investors’ attention. The bearish pattern—which shows up when the 50-day moving average crosses under its 200-day moving average—can serve as a sign of more trouble ahead.
For the followi... Read the Full Story |
|
Technology | |
On multiple occasions this year, President Donald Trump has publicly shown his support for Dell Technologies (NYSE: DELL), telling Americans to “go out and buy a Dell computer” as recently as July 6.
In doing so, he has shone a light on one of the best-performing stocks over the past year.
Since it... Read the Full Story |
|
From Our Partners | | Goldman Sachs says 40 percent of AI data centers could face electricity shortfalls by 2027 as demand grows 15 percent a year and the grid struggles to keep pace.
One overlooked Texas company collects a royalty on nearly every drop of oil and cubic foot of natural gas moving through the country - effectively getting paid on every Nvidia chip produced. It still trades like a sleepy industrial name.
Goldman identified the problem. See the stock some think could be part of the solution. | | See the stock tied to AI's growing power crisis |
|
Consumer Discretionary | |
Amazon.com Inc. (NASDAQ: AMZN) has built its empire on a relentless obsession with doing things faster and cheaper, so news that it's quietly working to automate one of the last stubbornly manual corners of its operation should surprise nobody. What might raise an eyebrow is just how ambitious the ... Read the Full Story |
|
Technology | |
Palo Alto Networks (NASDAQ: PANW) is no cheap stock, trading at roughly 78x its fiscal 2027 (FY2027) guidance and 18x its long-term forecast, but its setup looks compelling, especially on dips.
The Q4 FY2026 results revealed that its platformization strategy continues to gain traction, momentum is... Read the Full Story |
|
Industrials | |
Defense technology has been one of the market's most volatile and arguably talked-about themes in 2026, apart from artificial intelligence, of course. But the gains across the sector have been far from evenly distributed.
AeroVironment (NASDAQ: AVAV) is proof of that. While many of its peers have ... Read the Full Story |
|
Technology | |
MongoDB’s (NASDAQ: MDB) early-September price pullback is a buy-the-dip event, triggered by sell-the-news profit-taking. The key takeaway from the company's Q2 fiscal year (FY2027) earnings report is that the business is accelerating under the influence of AI. AI aids not only internals but also of... Read the Full Story |
|
Consumer Discretionary | |
Any investor looking for a bargain might have a natural home in Burlington Stores Inc. (NYSE: BURL), the off-price retailer whose whole appeal rests on selling brand-name goods for less. There’s a certain irony in the fact that its own shares have been selling off heavily in recent weeks, and are c... Read the Full Story |
|
Friday's Early Bird Stock Of The Day Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana. | Should I Buy Eli Lilly and Company Stock? LLY Bull and Bear Case Explained
These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Eli Lilly and Company was last updated on Sunday, August 30, 2026 at 6:03 PM.
Eli Lilly and Company Bull Case -
The company recently reported earnings per share (EPS) of $8.38, significantly exceeding analysts' expectations, indicating strong financial performance.
-
Eli Lilly and Co has a robust net margin of over 33%, suggesting efficient management and profitability, which can lead to higher returns for investors.
-
The stock has shown impressive revenue growth, with a year-over-year increase of nearly 48%, reflecting strong demand for its products.
-
The current stock price is around $1,190, which is near its twelve-month high, indicating strong market confidence in the company's future prospects.
-
The company has a solid dividend payout ratio of 23.22%, providing a steady income stream for investors through its quarterly dividends.
Eli Lilly and Company Bear Case -
The stock has a relatively high price-to-earnings (P/E) ratio of 39.23, which may suggest that it is overvalued compared to its earnings potential.
-
With a beta of 0.51, the stock is less volatile than the market, which may limit potential gains during bullish market conditions.
-
The company has a debt-to-equity ratio of 1.41, indicating a higher level of debt compared to equity, which could pose risks in economic downturns.
-
Insider selling activity has been noted, with significant shares sold recently, which may raise concerns about the company's future outlook from those closest to it.
-
The dividend yield is relatively low at 0.6%, which may not be attractive for income-focused investors compared to other investment opportunities.
| | View Today's Stock Pick |
|
